Loading...
3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China
BACKGROUND AND AIMS: Tenofovir alafenamide (TAF) has similar efficacy to tenofovir disoproxil fumarate (TDF) but with improved renal and bone safety in chronic hepatitis B patients studied outside of China. We report 3-year results from two phase 3 studies with TAF in China (Clinicaltrials.gov: NCT0...
Na minha lista:
| Udgivet i: | J Clin Transl Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
XIA & HE Publishing Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8237145/ https://ncbi.nlm.nih.gov/pubmed/34221918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2020.00145 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|